KELLY WALWORTH: Open Payments
NPI 1376526756 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,293 in 168 payments from 18 companies in 2025. Trend: 2023 $2,928 · 2024 $3,835 · 2025 $3,293
Food & beverage: $2,994Education: $299
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $494 |
| PFIZER INC. | 24 | $446 |
| Novartis Pharmaceuticals Corporation | 16 | $354 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $252 |
| Regeneron Healthcare Solutions, Inc. | 13 | $243 |
| UCB, Inc. | 14 | $223 |
| GENZYME CORPORATION | 10 | $221 |
| ABBVIE INC. | 15 | $214 |
| Galderma Laboratories, L.P. | 20 | $191 |
| LEO Pharma Inc. | 8 | $176 |
Products named: TREMFYA, DUPIXENT, CIBINQO, Bimzelx, NEMLUVIO, COSENTYX, ILUMYA, TALTZ.
Industry payments across OK — which companies pay providers there.
